UK Medical Research Regulators Spared the Axe
By Daniel Cressey,
Nature News Blog
| 07. 18. 2013
The future of the UK regulating bodies for human-embryo and human-tissue research has been safeguarded, as the government’s announcement yesterday that the two bodies will continue to exist brings a long-running saga to an end.
Back in 2010 the government said that it would axe the Human Fertilisation and Embryology Authority (HFEA), which regulates research on human embryos and fertility treatment. The Human Tissue Authority (HTA), which regulates other human tissue research and organ donation, was also to be wound up. The proposals were unpopular with many researchers, and
earlier this year the Department of Health announced that instead it would commission an independent review to see whether the two bodies could be merged.
That review —
published yesterday — found that there was “relatively little overlap” in the work of the two regulators and they should continue as separate bodies. This outcome has been
accepted by the government.
There will be some changes for researchers. Regulation of tissue used for developing medicinal products is to be transferred from the HTA to the UK Medicines and Healthcare Products Regulatory...
Related Articles
By Philip Ball, Quanta Magazine | 06.18.2026
Since its molecular structure was deduced in the 1950s, DNA has been hailed by many biologists as the secret of life. They’ve read and studied the information stored in the DNA found in the cells of living organisms, known as...
By Jennifer Takhar, Carolyn Wilson-Nash, and Chloe He, BioNews | 06.22.2026
Imagine wanting to have a child and discovering, at every stage, that the system was not designed with you in mind. This is the reality for many LGBTQ+ people in the UK who seek fertility treatment each year.
Our study...
By Mark Ellwood, Air Mail | 06.06.2026
How much would you pay to be a parent? For years, Americans who turned to surrogacy could expect to spend about $100,000 on what the industry calls the “surrogacy journey.” For deep-pocketed intended parents—the term for those who plan to...
By Carl Zimmer, The New York Times | 06.04.2026
Scientists at Columbia University have edited the DNA of early human embryos with unprecedented accuracy, an achievement that could open the way to babies engineered with particular characteristics.
The prospect has fueled controversy for years. On the one hand, the...